Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme

Brain Pathology

Volumn 7, Issue 3, 1997, Pages 871-875

  Hayashi, Yutaka ^a   Ueki, Keisuke ^b   Waha, Andreas ^a   Wiestler, Otmar D ^a   Louis, David N ^b   Von Deimling, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BRAIN BIOPSY; CARCINOGENESIS; GENE AMPLIFICATION; GENE DELETION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY;

EID: 0030797470     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1997.tb00890.x     Document Type: Article

References (29)

1. Asano K, Sakamoto H, Sasaki H, Ochiya T, Yoshida T, Ohishi Y, Machida T. Kakizoe T, Sugimura T, Terada M (1995) Tumorigenicity and gene amplification potentials of cyclin D1-overexpxressing NIH3T3 cells. Biochem Biophys Res Commun 217: 1169-1176
2. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47: 191-205
3. Burger PC, Green SB (1987) Patient age, histologie features, and length of survival in patients with ghoblastoma multiforme. Cancer 59: 1617-1625
4. Carrol SM, DeRose ML, Gaudray P, Moore CM, Needham-Vandevanter DR, Von Hoff DD, Wahl GM (1988) Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol 8: 1525-1533
5. Debbas M, White E (1993) Wild-type P53 mediates apoptosis by El A, which is inhibited E1B. Genes Develop 7: 546-554
6. Englert C, Hou X, Maheswaran S, Bennet P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14: 4662-4675
7. Giani C, Finocchiaro G (1994) Mutation rate of the CDKN2 gene in malignant glioas. Cancer Res 54: 63386339
8. Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophystology. Mol Biol Cell 4: 121-133
9. Hartwell L (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer. Cell 71: 543-546
10. James CD, Carlblom E, Dumanski JP, Hansen M, Nordenskjoid M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551
11. Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353-6358
12. Louis DN (1994) The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53: 11-21
13. Louis DN, Gusella JF (1995) A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415
14. Louis DN, von Deimling A, Chung RY, Rubio MP, Whaley JH, Eibl R, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytoma. J Neuropathol Exp Neurol 52: 31-38
15. Nagane M, Coufal F, Lin H, BoegLer O, Cavenee WK, Huang H-JS (1996) A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56: 5079-5089
16. Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN (1996) Malignant astrocytomas with homozygous CDKN2 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 55: 1026-1031
17. Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH (1994) Alterations of the TP53 gene in human gliomas. Cancer Res 54-1324-30
18. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M (1994) Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cane 56: 72-77
19. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1995) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321-6324
20. Ueki K, Ono Y, Henson JW, von Deimling A, Louis DN (1996) CDKN2 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56: 150-153
21. von Deimling A, Louis DN, Wiestier OD (1995) Molecular pathways in the formation of gliomas. Glia 15, 328-338
22. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3: 19-26
23. Waha A, Rollbrocker B, Wiestler OD, von Deimling A (1996) A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors. Diagnostic Molecular Pathology 5: 147-150
24. Walker D, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55: 20-23
25. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-223
26. Wellenreuther R, Kraus J, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Path 146: 827-832
27. Windle B, Draper BW, Yin Y, O'Gorman S, Wahl GM (1991) A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Devel 5: 160-174
28. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J (1995) Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95: 1897-1905
29. Zhou P, Jiang W, Weghorst CM, Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36-39